AKBA vs SWK · rev $102.7M vs P/E 34, rev $7.81B
Akebia Ther (AKBA) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
AKBA currently screens at market cap $260.1M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the AKBA and SWK stock pages for the full models.
Not investment advice.